.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Researchers recently identified a novel neuron-enriched long noncoding RNA (lncRNA) named Neuid. This specific transcript plays a pivotal role in maintaining the integrity of brain cells. Interestingly, studies show that Neuid in Alzheimer's disease is significantly downregulated. This reduction contributes to the loss of neuronal identity and subsequent cognitive decline. Consequently, understanding this molecular mechanism opens new avenues for therapeutic intervention.
Furthermore, mechanistically, Neuid acts as a guardian of neuronal fate. In addition, it achieves this by interacting with the Polycomb Repressive Complex 2 (PRC2). Specifically, it binds to the EZH2 subunit to regulate H3K27me3 levels. As a result, it silences non-neuronal genes effectively. Therefore, it prevents the expression of glial-related sequences within mature neurons. However, when Neuid levels drop, this epigenetic shield fails. Consequently, neurons begin to express inappropriate genes, which leads to cellular dysfunction.
Moreover, experimental models provide compelling evidence for the clinical relevance of Neuid. For instance, the knockdown of Neuid in healthy neurons results in impaired synaptic activity. It also causes significant memory formation deficits in animal subjects. Conversely, researchers used CRISPRa technology to overexpress Neuid in Aβ42-treated neurons. This intervention successfully restored network function and neuronal plasticity. Thus, targeting this lncRNA could potentially reverse some aspects of AD pathology. Finally, these findings position Neuid as a promising biomarker and drug target.
Neuid is a neuron-specific lncRNA that helps maintain the identity of neurons. In Alzheimer's disease, its levels decrease significantly, which causes neurons to lose their function and leads to memory impairment.
It interacts with the EZH2 subunit of the PRC2 complex to facilitate H3K27me3. This epigenetic process silences genes that should not be active in mature neurons, such as glial or developmental genes.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare. Always consult a qualified medical practitioner for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Neuid is a neuron-specific lncRNA downregulated in Alzheimer's that maintains neuronal identity by regulating epigenetic gene silencing via the PRC2 complex...
5 months ago
A clinical comparison of extravascular and subcutaneous implantable cardioverter-defibrillators, detailing patient selection, pacing capabilities, and implantation nuances.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
